ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
leverage factor · long-only model fund

Foundry Book Leverage Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FBOOHYPOTHETICAL MODEL
Since ’99
−58%
Expense Ratio
0.29%
placeholder
Holdings
286
cap-weighted
Inception
Aug 2022
placeholder
Full Sharpe
-0.01
Ann. Return (LS)
-0.3%
Ann. Volatility
23.6%
Max Drawdown
-88.3%
Test Sharpe ’19–26
-0.25
Test FF5 α (ann.)
-0.6%
vs Fama-French 5
Test FF5 α t-stat
-0.11
not significant
Monthly turnover
8%
of the long leg, per rebalance
Cumulative return (LS)
-58%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.35
what this fund holds
Long leg ann. return
9.5%
buyable, long-only
Long-short Sharpe
-0.01
requires shorting
Bottom bucket ann. return
9.8%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

286 of 286 · 100.0% of book
TickerCompanySectorMarket capWeight
1AMD
ADVANCED MICRO DEVICES INCTechnology$808.39B
30.64%
2PLTR
PALANTIR TECHNOLOGIES INCTechnology$317.36B
12.03%
3SNDK
SANDISK CORPTechnology$200.63B
7.60%
4ISRG
INTUITIVE SURGICAL INCHealthcare$122.33B
4.64%
5MNST
MONSTER BEVERAGE CORPConsumer Defensive$95.36B
3.61%
6MPWR
MONOLITHIC POWER SYSTEMS INCTechnology$64.46B
2.44%
7ALAB
ASTERA LABS INCTechnology$52.04B
1.97%
8GRMN
GARMIN LTDTechnology$48.13B
1.82%
9RKLB
ROCKET LAB CORPIndustrials$39.14B
1.48%
10CRDO
CREDO TECHNOLOGY GROUP HOLDING LTDTechnology$37.80B
1.43%
11RDDT
REDDIT INCCommunication Services$34.88B
1.32%
12TWLO
TWILIO INCCommunication Services$31.38B
1.19%
13TPL
TEXAS PACIFIC LAND CORPEnergy$28.67B
1.09%
14ZM
ZOOM COMMUNICATIONS INCTechnology$26.72B
1.01%
15CPRT
COPART INCIndustrials$25.56B
0.97%
16UTHR
UNITED THERAPEUTICS CORPHealthcare$22.74B
0.86%
17LSCC
LATTICE SEMICONDUCTOR CORPTechnology$17.16B
0.65%
18SITM
SITIME CORPTechnology$14.65B
0.56%
19ONTO
ONTO INNOVATION INCTechnology$13.92B
0.53%
20PS
PERSHING SQUARE INCFinancial Services$13.70B
0.52%
21MLI
MUELLER INDUSTRIES INCIndustrials$13.08B
0.50%
22GGG
GRACO INCIndustrials$12.38B
0.47%
23AUR
AURORA INNOVATION INCTechnology$11.88B
0.45%
24TECH
BIO-TECHNE CORPHealthcare$11.29B
0.43%
25RMBS
RAMBUS INCTechnology$10.97B
0.42%
26VICR
VICOR CORPTechnology$10.83B
0.41%
27SMMT
SUMMIT THERAPEUTICS INCHealthcare$10.72B
0.41%
28KRYS
KRYSTAL BIOTECH INCHealthcare$10.46B
0.40%
29GMED
GLOBUS MEDICAL INCHealthcare$10.45B
0.40%
30APGE
APOGEE THERAPEUTICS INCHealthcare$10.10B
0.38%
31NUVL
NUVALENT INCHealthcare$9.79B
0.37%
32KYMR
KYMERA THERAPEUTICS INCHealthcare$9.52B
0.36%
33BMNR
BITMINE IMMERSION TECHNOLOGIES INCFinancial Services$9.46B
0.36%
34PTGX
PROTAGONIST THERAPEUTICS INCHealthcare$9.06B
0.34%
35SAIL
SAILPOINT INCTechnology$8.89B
0.34%
36CRNX
CRINETICS PHARMACEUTICALS INCHealthcare$8.84B
0.34%
37PRAX
PRAXIS PRECISION MEDICINES INCHealthcare$8.77B
0.33%
38SYRE
SPYRE THERAPEUTICS INCHealthcare$8.70B
0.33%
39KTOS
KRATOS DEFENSE & SECURITY SOLUTIONS INCIndustrials$8.63B
0.33%
40IMVT
IMMUNOVANT INCHealthcare$8.27B
0.31%
41FORM
FORMFACTOR INCTechnology$8.23B
0.31%
42PCVX
VAXCYTE INCHealthcare$8.12B
0.31%
43MBLY
MOBILEYE GLOBAL INCConsumer Cyclical$7.76B
0.29%
44ZG
ZILLOW GROUP INCCommunication Services$7.71B
0.29%
45TTAN
SERVICETITAN INCTechnology$7.25B
0.27%
46SLAB
SILICON LABORATORIES INCTechnology$7.17B
0.27%
47OKLO
OKLO INCUtilities$7.15B
0.27%
48CRUS
CIRRUS LOGIC INCTechnology$6.98B
0.26%
49XENE
XENON PHARMACEUTICALS INCHealthcare$6.60B
0.25%
50APPF
APPFOLIO INCTechnology$6.36B
0.24%
51CGON
CG ONCOLOGY INCHealthcare$6.34B
0.24%
52QBTS
D-WAVE QUANTUM INCTechnology$6.19B
0.23%
53ERAS
ERASCA INCHealthcare$5.96B
0.23%
54MBGL
MOBILITY GLOBAL INCTechnology$5.93B
0.22%
55DNTH
DIANTHUS THERAPEUTICS INCHealthcare$5.77B
0.22%
56VSEC
VSE CORPIndustrials$5.60B
0.21%
57ORKA
ORUKA THERAPEUTICS INCHealthcare$5.59B
0.21%
58TXG
10X GENOMICS INCHealthcare$5.55B
0.21%
59GNTX
GENTEX CORPConsumer Cyclical$5.19B
0.20%
60VCYT
VERACYTE INCHealthcare$4.72B
0.18%
61RGTI
RIGETTI COMPUTING INCTechnology$4.69B
0.18%
62MANE
VERADERMICS INCHealthcare$4.65B
0.18%
63DLB
DOLBY LABORATORIES INCIndustrials$4.64B
0.18%
64UEC
URANIUM ENERGY CORPBasic Materials$4.59B
0.17%
65IPGP
IPG PHOTONICS CORPTechnology$4.43B
0.17%
66OCTV
OCTAVE INTELLIGENCE PLCTechnology$4.42B
0.17%
67VKTX
VIKING THERAPEUTICS INCHealthcare$4.31B
0.16%
68EWTX
EDGEWISE THERAPEUTICS INCHealthcare$4.28B
0.16%
69GPGI
GPGI INCIndustrials$4.21B
0.16%
70CALM
CAL-MAINE FOODS INCConsumer Defensive$4.20B
0.16%
71TNGX
TANGO THERAPEUTICS INCHealthcare$4.13B
0.16%
72BETA
BETA TECHNOLOGIES INCIndustrials$4.10B
0.16%
73DOCS
DOXIMITY INCHealthcare$3.94B
0.15%
74POWI
POWER INTEGRATIONS INCTechnology$3.93B
0.15%
75DYN
DYNE THERAPEUTICS INCHealthcare$3.92B
0.15%
76LASR
NLIGHT INCTechnology$3.91B
0.15%
77CPRX
CATALYST PHARMACEUTICALS INCHealthcare$3.85B
0.15%
78RLAY
RELAY THERAPEUTICS INCHealthcare$3.81B
0.14%
79OLED
UNIVERSAL DISPLAY CORPTechnology$3.75B
0.14%
80PAY
PAYMENTUS HOLDINGS INCTechnology$3.75B
0.14%
81ALMS
ALUMIS INCHealthcare$3.65B
0.14%
82QS
QUANTUMSCAPE CORPConsumer Cyclical$3.60B
0.14%
83AB
ALLIANCEBERNSTEIN HOLDING LPFinancial Services$3.54B
0.13%
84USAR
USA RARE EARTH INCBasic Materials$3.49B
0.13%
85XXI
TWENTY ONE CAPITAL INCIndustrials$3.48B
0.13%
86GPCR
STRUCTURE THERAPEUTICS INCHealthcare$3.45B
0.13%
87ELVN
ENLIVEN THERAPEUTICS INCHealthcare$3.24B
0.12%
88IDYA
IDEAYA BIOSCIENCES INCHealthcare$3.16B
0.12%
89GRAL
GRAIL INCHealthcare$3.12B
0.12%
90USLM
UNITED STATES LIME & MINERALS INCBasic Materials$3.01B
0.11%
91MBX
MBX BIOSCIENCES INCHealthcare$2.99B
0.11%
92XNDU
XANADU QUANTUM TECHNOLOGIES LTDTechnology$2.98B
0.11%
93IRON
DISC MEDICINE INCHealthcare$2.91B
0.11%
94SMR
NUSCALE POWER CORPIndustrials$2.82B
0.11%
95CLDX
CELLDEX THERAPEUTICS INCHealthcare$2.77B
0.11%
96VERA
VERA THERAPEUTICS INCHealthcare$2.76B
0.10%
97VISN
VISTANCE NETWORKS INCTechnology$2.74B
0.10%
98TRVI
TREVI THERAPEUTICS INCHealthcare$2.71B
0.10%
99NVTS
NAVITAS SEMICONDUCTOR CORPTechnology$2.68B
0.10%
100AEHR
AEHR TEST SYSTEMSTechnology$2.55B
0.10%
101IMNM
IMMUNOME INCHealthcare$2.53B
0.10%
102RUM
RUMBLE INCTechnology$2.51B
0.10%
103SLS
SELLAS LIFE SCIENCES GROUP INCHealthcare$2.45B
0.09%
104SPSC
SPS COMMERCE INCTechnology$2.41B
0.09%
105ROG
ROGERS CORPTechnology$2.36B
0.09%
106AGIO
AGIOS PHARMACEUTICALS INCHealthcare$2.36B
0.09%
107YSS
YORK SPACE SYSTEMS INCIndustrials$2.33B
0.09%
108PVLA
PALVELLA THERAPEUTICS INCHealthcare$2.26B
0.09%
109MLYS
MINERALYS THERAPEUTICS INCHealthcare$2.23B
0.08%
110SION
SIONNA THERAPEUTICS INCHealthcare$2.23B
0.08%
111HTFL
HEARTFLOW INCHealthcare$2.15B
0.08%
112AXGN
AXOGEN INCHealthcare$2.12B
0.08%
113PPTA
PERPETUA RESOURCES CORPBasic Materials$2.11B
0.08%
114RAPP
RAPPORT THERAPEUTICS INCHealthcare$2.04B
0.08%
115PLSE
PULSE BIOSCIENCES INCHealthcare$1.98B
0.08%
116INFQ
INFLEQTION INCTechnology$1.98B
0.08%
117AMLX
AMYLYX PHARMACEUTICALS INCHealthcare$1.97B
0.07%
118DMRA
DAMORA THERAPEUTICS INCHealthcare$1.94B
0.07%
119TYRA
TYRA BIOSCIENCES INCHealthcare$1.91B
0.07%
120VRDN
VIRIDIAN THERAPEUTICS INCHealthcare$1.86B
0.07%
121PRLB
PROTO LABS INCIndustrials$1.85B
0.07%
122SSMR
SUNSHINE MINING & REFINING COBasic Materials$1.83B
0.07%
123BCAX
BICARA THERAPEUTICS INCHealthcare$1.82B
0.07%
124STOK
STOKE THERAPEUTICS INCHealthcare$1.81B
0.07%
125QUBT
QUANTUM COMPUTING INCTechnology$1.76B
0.07%
126DV
DOUBLEVERIFY HOLDINGS INCTechnology$1.75B
0.07%
127HYMC
HYCROFT MINING HOLDING CORPBasic Materials$1.74B
0.07%
128GENB
GENERATE BIOMEDICINES INCHealthcare$1.74B
0.07%
129MPLT
MAPLIGHT THERAPEUTICS INCHealthcare$1.72B
0.07%
130NTLA
INTELLIA THERAPEUTICS INCHealthcare$1.59B
0.06%
131MAZE
MAZE THERAPEUTICS INCHealthcare$1.56B
0.06%
132AMBQ
AMBIQ MICRO INCTechnology$1.55B
0.06%
133AVBP
ARRIVENT BIOPHARMA INCHealthcare$1.55B
0.06%
134VIA
VIA TRANSPORTATION INCTechnology$1.46B
0.06%
135INSP
INSPIRE MEDICAL SYSTEMS INCHealthcare$1.46B
0.06%
136MRTN
MARTEN TRANSPORT LTDIndustrials$1.44B
0.05%
137AMPX
AMPRIUS TECHNOLOGIES INCIndustrials$1.44B
0.05%
138BLFS
BIOLIFE SOLUTIONS INCHealthcare$1.42B
0.05%
139AI
C3AI INCTechnology$1.37B
0.05%
140AKTS
AKTIS ONCOLOGY INCHealthcare$1.33B
0.05%
141DMLP
DORCHESTER MINERALS LPEnergy$1.31B
0.05%
142ABSI
ABSCI CORPHealthcare$1.29B
0.05%
143IE
IVANHOE ELECTRIC INCBasic Materials$1.29B
0.05%
144NRP
NATURAL RESOURCE PARTNERS LPBasic Materials$1.28B
0.05%
145TRAX
FIRST TRACKS BIOTHERAPEUTICS INCUnclassified$1.27B
0.05%
146CRVS
CORVUS PHARMACEUTICALS INCHealthcare$1.25B
0.05%
147IRMD
IRADIMED CORPHealthcare$1.24B
0.05%
148AZTA
AZENTA INCHealthcare$1.21B
0.05%
149NPKI
NPK INTERNATIONAL INCEnergy$1.21B
0.05%
150CAPR
CAPRICOR THERAPEUTICS INCHealthcare$1.13B
0.04%
151WVE
WAVE LIFE SCIENCES LTDHealthcare$1.12B
0.04%
152ORIC
ORIC PHARMACEUTICALS INCHealthcare$1.11B
0.04%
153CGEM
CULLINAN THERAPEUTICS INCHealthcare$1.09B
0.04%
154CEVA
CEVA INCTechnology$1.06B
0.04%
155JBIO
JADE BIOSCIENCES INCHealthcare$1.03B
0.04%
156BIOA
BIOAGE LABS INCHealthcare$1.01B
0.04%
157OLMA
OLEMA PHARMACEUTICALS INCHealthcare$1.00B
0.04%
158JANX
JANUX THERAPEUTICS INCHealthcare$992M
0.04%
159ANRO
ALTO NEUROSCIENCE INCHealthcare$967M
0.04%
160LWLG
LIGHTWAVE LOGIC INCBasic Materials$960M
0.04%
161RCAT
RED CAT HOLDINGS INCTechnology$938M
0.04%
162AOSL
ALPHA & OMEGA SEMICONDUCTOR LTDTechnology$936M
0.04%
163RDVT
RED VIOLET INCTechnology$920M
0.03%
164LBRX
LB PHARMACEUTICALS INCHealthcare$901M
0.03%
165PURR
HYPERLIQUID STRATEGIES INCFinancial Services$899M
0.03%
166TALK
TALKSPACE INCHealthcare$873M
0.03%
167NPK
NATIONAL PRESTO INDUSTRIES INCIndustrials$870M
0.03%
168SLDB
SOLID BIOSCIENCES INCHealthcare$859M
0.03%
169NNE
NANO NUCLEAR ENERGY INCIndustrials$835M
0.03%
170AVR
ANTERIS TECHNOLOGIES GLOBAL CORPHealthcare$823M
0.03%
171UMAC
UNUSUAL MACHINES INCIndustrials$809M
0.03%
172UAMY
UNITED STATES ANTIMONY CORPBasic Materials$809M
0.03%
173DSGN
DESIGN THERAPEUTICS INCHealthcare$785M
0.03%
174BBNX
BETA BIONICS INCHealthcare$771M
0.03%
175MNPR
MONOPAR THERAPEUTICSHealthcare$744M
0.03%
176CSTL
CASTLE BIOSCIENCES INCHealthcare$733M
0.03%
177CLYM
CLIMB BIO INCHealthcare$727M
0.03%
178BBOT
BRIDGEBIO ONCOLOGY THERAPEUTICS INCHealthcare$686M
0.03%
179PKE
PARK AEROSPACE CORPIndustrials$677M
0.03%
180SGP
SPYGLASS PHARMA INCHealthcare$661M
0.03%
181MNTN
MNTN INCTechnology$661M
0.03%
182FISN
DEEP FISSION INCIndustrials$643M
0.02%
183LEGH
LEGACY HOUSING CORPConsumer Cyclical$637M
0.02%
184TECX
TECTONIC THERAPEUTIC INCHealthcare$615M
0.02%
185RGR
STURM RUGER & CO INCIndustrials$604M
0.02%
186NGNE
NEUROGENE INCHealthcare$590M
0.02%
187STTK
SHATTUCK LABS INCHealthcare$577M
0.02%
188FDMT
4D MOLECULAR THERAPEUTICS INCHealthcare$575M
0.02%
189FLGT
FULGENT GENETICS INCHealthcare$573M
0.02%
190IMMX
IMMIX BIOPHARMA INCHealthcare$558M
0.02%
191RLMD
RELMADA THERAPEUTICS INCHealthcare$550M
0.02%
192XMAX
XMAX INCConsumer Cyclical$541M
0.02%
193EBF
ENNIS INCIndustrials$541M
0.02%
194CTNM
CONTINEUM THERAPEUTICS INCHealthcare$532M
0.02%
195ZURA
ZURA BIO LTDHealthcare$518M
0.02%
196SD
SANDRIDGE ENERGY INCEnergy$503M
0.02%
197GDYN
GRID DYNAMICS HOLDINGS INCTechnology$484M
0.02%
198SGMT
SAGIMET BIOSCIENCES INCHealthcare$479M
0.02%
199CWCO
CONSOLIDATED WATER CO LTDUtilities$467M
0.02%
200PRTA
PROTHENA CORP PUBLIC LTD COHealthcare$453M
0.02%
201IDR
IDAHO STRATEGIC RESOURCES INCBasic Materials$449M
0.02%
202SI
SHOULDER INNOVATIONS INCHealthcare$448M
0.02%
203SRTA
STRATA CRITICAL MEDICAL INCIndustrials$446M
0.02%
204ERII
ENERGY RECOVERY INCIndustrials$444M
0.02%
205DCTH
DELCATH SYSTEMS INCHealthcare$442M
0.02%
206BNTC
BENITEC BIOPHARMA INCHealthcare$439M
0.02%
207EVMN
EVOMMUNE INCHealthcare$437M
0.02%
208ASMB
ASSEMBLY BIOSCIENCES INCHealthcare$426M
0.02%
209TENX
TENAX THERAPEUTICS INCHealthcare$420M
0.02%
210NVEC
NVE CORPTechnology$418M
0.02%
211CLFD
CLEARFIELD INCTechnology$416M
0.02%
212SWMR
SWARMER INCTechnology$410M
0.02%
213CBIO
CRESCENT BIOPHARMA INCHealthcare$407M
0.02%
214SERV
SERVE ROBOTICS INCIndustrials$394M
0.01%
215DMAC
DIAMEDICA THERAPEUTICS INCHealthcare$393M
0.01%
216UPB
UPSTREAM BIO INCHealthcare$382M
0.01%
217WEYS
WEYCO GROUP INCConsumer Cyclical$374M
0.01%
218SLP
SIMULATIONS PLUS INCHealthcare$369M
0.01%
219ELMD
ELECTROMED INCHealthcare$349M
0.01%
220MRAM
EVERSPIN TECHNOLOGIES INCTechnology$341M
0.01%
221MPTI
M-TRON INDUSTRIES INCTechnology$328M
0.01%
222BKKT
BAKKT INCTechnology$323M
0.01%
223MSB
MESABI TRUSTBasic Materials$320M
0.01%
224GUACU
BERTO ACQUISITION CORP IIIndustrials$318M
0.01%
225SSSS
SURO CAPITAL CORPFinancial Services$317M
0.01%
226OSS
ONE STOP SYSTEMS INCTechnology$313M
0.01%
227GUAC
BERTO ACQUISITION CORP IIIndustrials$311M
0.01%
228CIX
COMPX INTERNATIONAL INCIndustrials$309M
0.01%
229OFLX
OMEGA FLEX INCIndustrials$302M
0.01%
230TRDA
ENTRADA THERAPEUTICS INCHealthcare$268M
0.01%
231ALMU
AELUMA INCTechnology$267M
0.01%
232NSLR
NEOSTELLAR CAPITAL CORPFinancial Services$266M
0.01%
233CNXU
CONEXEU SCIENCES INCHealthcare$263M
0.01%
234ZSQR
Z SQUARED INCHealthcare$260M
0.01%
235PCYO
PURE CYCLE CORPUtilities$258M
0.01%
236LTBR
LIGHTBRIDGE CORPIndustrials$256M
0.01%
237RELL
RICHARDSON ELECTRONICS LTDTechnology$250M
0.01%
238ARTV
ARTIVA BIOTHERAPEUTICS INCHealthcare$241M
0.01%
239DUOT
DUOS TECHNOLOGIES GROUP INCTechnology$241M
0.01%
240GENC
GENCOR INDUSTRIES INCIndustrials$235M
0.01%
241USAU
US GOLD CORPBasic Materials$235M
0.01%
242RXST
RXSIGHT INCHealthcare$230M
0.01%
243UTMD
UTAH MEDICAL PRODUCTS INCHealthcare$222M
0.01%
244ATOM
ATOMERA INCTechnology$218M
0.01%
245KROS
KEROS THERAPEUTICS INCHealthcare$211M
0.01%
246GSIT
GSI TECHNOLOGY INCTechnology$208M
0.01%
247AIRO
AIRO GROUP HOLDINGS INCIndustrials$205M
0.01%
248TNXP
TONIX PHARMACEUTICALS HOLDING CORPHealthcare$198M
0.01%
249WHG
WESTWOOD HOLDINGS GROUP INCFinancial Services$188M
0.01%
250ACOG
ALPHA COGNITION INCHealthcare$185M
0.01%
251SBMT
SILVER BOW MINING CORPBasic Materials$185M
0.01%
252KVHI
KVH INDUSTRIES INCTechnology$178M
0.01%
253TAYD
TAYLOR DEVICES INCIndustrials$176M
0.01%
254AMPG
AMPLITECH GROUP INCTechnology$168M
0.01%
255CRBP
CORBUS PHARMACEUTICALS HOLDINGS INCHealthcare$167M
0.01%
256LENZ
LENZ THERAPEUTICS INCHealthcare$162M
0.01%
257CHCI
COMSTOCK HOLDING COMPANIES INCReal Estate$162M
0.01%
258TRAK
REPOSITRAK INCTechnology$160M
0.01%
259EXOD
EXODUS MOVEMENT INCTechnology$152M
0.01%
260PMN
PROMIS NEUROSCIENCES INCHealthcare$136M
0.01%
261AXR
AMREP CORPReal Estate$136M
0.01%
262VTVT
VTV THERAPEUTICS INCHealthcare$130M
0.00%
263AARD
AARDVARK THERAPEUTICS INCHealthcare$128M
0.00%
264BUDA
BUDA JUICE INCUnclassified$121M
0.00%
265AMCI
AMC ROBOTICS CORPTechnology$114M
0.00%
266CODA
CODA OCTOPUS GROUP INCIndustrials$113M
0.00%
267FWACU
FUTUREWAVE ACQUISITION CORPIndustrials$113M
0.00%
268FXACU
FORTUNEX ACQUISITION CORPIndustrials$110M
0.00%
269FXAC
FORTUNEX ACQUISITION CORPIndustrials$110M
0.00%
270USGO
US GOLDMINING INCBasic Materials$109M
0.00%
271ROC
RANK ONE COMPUTING CORPTechnology$98M
0.00%
272RACD
RESEARCH ALLIANCE CORP IVIndustrials$95M
0.00%
273OPXS
OPTEX SYSTEMS HOLDINGS INCIndustrials$89M
0.00%
274MHH
MASTECH DIGITAL INCIndustrials$89M
0.00%
275RLYB
RALLYBIO CORPHealthcare$87M
0.00%
276IOR
INCOME OPPORTUNITY REALTY INVESTORS INCFinancial Services$84M
0.00%
277WATT
ENERGOUS CORPTechnology$83M
0.00%
278FRMM
FORUM MARKETS INCHealthcare$83M
0.00%
279AUC
ATIF HOLDINGS LTDFinancial Services$82M
0.00%
280ROLR
HIGH ROLLER TECHNOLOGIES INCConsumer Cyclical$76M
0.00%
281ACET
ADICET BIO INCHealthcare$76M
0.00%
282AGPU
AXE COMPUTE INCHealthcare$72M
0.00%
283BGSF
BGSF INCIndustrials$65M
0.00%
284IMA
IMAGENEBIO INCHealthcare$61M
0.00%
285EDSA
EDESA BIOTECH INCHealthcare$59M
0.00%
286APT
ALPHA PRO TECH LTDBasic Materials$53M
0.00%

Full long-leg book as of July 2026 · cap-weighted · total market cap $2.64T. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

12 sectors
Technology
66.6%
Healthcare
17.3%
Industrials
5.3%
Consumer Defensive
3.8%
Communication Services
2.8%
Energy
1.2%
Financial Services
1.1%
Basic Materials
0.9%
Consumer Cyclical
0.7%
Utilities
0.3%
Unclassified
0.1%
Real Estate
0.0%

Portfolio Style

Size × value map of the long-leg book

286 classified
Value
Blend
Growth
Large
Mid
Small
1%2
8%17
78%37
2%20
4%52
4%37
1%45
1%44
<1%18

Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 94% toward Large, 90% toward Growth. +1% unclassified (14 missing size/value). Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt94% → Large
SmallLarge
Value ↔ growth tilt90% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 286 names now. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
1
Failed
4
Not tested
2
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • With respect to 75% of total assets, no more than 5% may be invested in the securities of any one issuer.

    Required
    >= 75.0%
    Actual
    64.7%
    Margin
    -10.3%
  • No more than 25% of total assets may be invested in the securities of any one issuer.

    Required
    <= 25.0%
    Actual
    30.6%
    Margin
    -5.6%
  • The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).

    Required
    <= 25.0%
    Actual
    42.3%
    Margin
    -17.3%
  • Days required to liquidate the largest position at 20% of one day's dollar volume.

    Required
    <= 7.0 days
    Actual
    unbounded
    Margin
Reported separately — arithmetically implied

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

No verdict sits within 1.0pp of its limit.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 286 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
2.1 (95% CI 1.3-3.1)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
19.8%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
2.05x
over
parametric
1.77x
within
cornish fisher
2.05x
over

The estimators disagree about the verdict, not just the value — the choice of method decides the answer here. Historical VaR gives ratio 2.05 (fail) but Gaussian VaR gives 1.77 (pass). The pass/fail conclusion is an artefact of estimator choice, not a property of the strategy.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

published 1992
Entirely since publication
All 331 months of our record post-date the 1992 paper.
Sharpe -0.01-0.3% p.a.January 1999July 2026

There is no “before” to compare against — the predictor was already public when our data begins, so every month shown is out-of-sample relative to the original study.

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
46%
12 of 26 3-year windows made money
Worst window
-1.18
Sharpe, January 2021 – December 2023
January 1999July 2026
Median Sharpe
-0.05
Dispersion
0.60
Best window
1.15

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.30.3%9.1%
3 yearsp.a.20.1%-2.1%
5 yearsp.a.1.8%-11.0%
10 yearsp.a.9.1%-6.2%
Since inceptionp.a.5.8%-3.1%
Calendar years
YearLong legLong-short
20267 mo15.3%6.3%
202527.8%5.3%
202411.3%-14.7%
202327.8%7.1%
2022-40.5%-28.6%
2021-7.9%-35.6%
202036.8%26.4%
201935.1%2.3%
2018-15.9%-3.8%
201737.1%6.5%
20163.4%-15.3%
201518.4%19.7%
201417.3%5.1%
201343.6%-3.4%
20128.8%-18.8%
20110.6%16.7%
201011.3%-0.1%
200958.6%21.0%
2008-41.6%20.9%
200719.4%44.8%
20061.7%-16.1%
200510.7%4.5%
200415.8%2.7%
200348.6%8.0%
2002-36.1%-24.8%
2001-47.8%-41.3%
2000-51.1%-61.3%
1999119.5%98.6%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FBOO
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.29% (placeholder)
Inception2022-08-17 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$2.64T

Methodology

The Foundry Book Leverage Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a Book Leverage signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.